IMNN - Imunon, Inc.
3.24
-0.100 -3.086%
Share volume: 19,382
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$3.34
-0.10
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-07-2024 | 02-27-2025 | 05-12-2025 | 08-05-2025 | 11-13-2025 | |
| Assets | ||||||||
| Total Assets | 14.325 M | 9.691 M | 14.391 M | 9.717 M | 6.862 M | 8.788 M | 8.988 M | |
| Current Assets | 12.094 M | 7.646 M | 12.532 M | 8.009 M | 5.092 M | 6.891 M | 7.258 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.285 M | 2.340 M | 2.220 M | 2.136 M | 2.220 M | 2.162 M | 2.007 M | |
| Short Term Investments | 7.462 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.347 M | 5.307 M | 10.312 M | 5.873 M | 2.872 M | 4.729 M | 5.251 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 693.360 K | 625.028 K | 563.602 K | 541.272 K | 734.243 K | 676.565 K | 601.425 K | |
| Other Assets | 1.537 M | 1.420 M | 1.295 M | 1.167 M | 1.036 M | 1.221 M | 1.129 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 14.325 M | 9.691 M | 14.391 M | 9.717 M | 6.862 M | 8.788 M | 8.988 M | |
| Total liabilities | 5.825 M | 5.950 M | 6.199 M | 5.473 M | 6.410 M | 6.128 M | 4.906 M | |
| Total current liabilities | 4.817 M | 5.077 M | 5.442 M | 4.786 M | 5.797 M | 5.317 M | 4.198 M | |
| Accounts Payable | 2.358 M | 1.969 M | 2.360 M | 1.300 M | 1.859 M | 1.736 M | 1.127 M | |
| Other liabilities | 1.008 M | 872.910 K | 757.726 K | 686.935 K | 613.171 K | 811.190 K | 708.097 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.008 M | 872.910 K | 757.726 K | 686.935 K | 613.171 K | 811.190 K | 708.097 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 8.500 M | 3.741 M | 8.192 M | 4.244 M | 452.028 K | 2.660 M | 4.082 M | |
| Common stock | 401.564 M | 401.727 M | 411.023 M | 411.133 M | 411.443 M | 416.391 M | 421.242 M | |
| Retained earnings | -393.112 M | -397.900 M | -402.746 M | -406.803 M | -410.906 M | -413.646 M | -417.075 M |